Back to results
US 11,629,240 B2Granted
Formulation of di(4-tert-butylcyclohexyl) peroxydicarbonate
AssigneeNouryon Chemicals International B.V.
InventorsGeesje Klasina Spijkerman, Auke Gerardus Talma, Markus Oliver Majoor, Antonie Den Braber, Martin Hermanus Maria Jansen
Life of this patent
Estimating the term…
Abstract
Powder formulation comprising 20-75 wt % of di(4-tert-butylcyclohexyl) peroxydicarbonate and 25-80 wt % of a phlegmatizer selected from the group consisting of ethylene glycol dibenzoate, phenyl benzoate, trimethylol propane tribenzoate, dimethylsulfon, ethylene glycol ditoluate, 1,3-propanediol ditoluate, ethylene glycol 4-tert-butylbenzoate, ethylene glycol monobenzoate monotoluate, 2,3-butanediol dibenzoate, 4-methylphenyl benzoate acid ester, and combinations thereof.
Claims20
A powder formulation comprising:
- 20-75 wt % of di(4-tert-butylcyclohexyl) peroxydicarbonate, and
- 25-80 wt % of a phlegmatizer,
- wherein the phlegmatizer comprises one or more of ethylene glycol dibenzoate, phenyl benzoate, trimethylol propane tribenzoate, dimethylsulfon, ethylene glycol ditoluate, 1,3-propanediol ditoluate, ethylene glycol 4-tert-butylbenzoate, ethylene glycol monobenzoate monotoluate, 2,3-butanediol dibenzoate, and 4-methylphenyl benzoate acid ester,
- wherein the di(4-tert-butylcyclohexyl) peroxydicarbonate has a particle size d90 of less than 100 microns, and the phlegmatizer has a particle size d90 less 500 microns.
1 more element
Dependencies are inferred from the claim text.